Form 4 for BBIO BridgeBio Pharma, Inc.
Accepted 2022-01-03 00:00:00 ET · period of report 2021-12-29 · accession 0000899243-22-000176 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-03 | 2021-12-29 | BBIO | Hassan Fred | Dir | P - Purchase | $14.17 | +19.3K | 19.3K | New | +$273.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-29 | P | A | 19,300 | $14.17 | 19,300 | D | — | — | (F1) Represents the weighted average purchase price of the shares purchased from $14.1250 to $14.2300 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions as reported in this footnote. |